Girish Prajapati
Biographic Data
| ID | 7730272 |
|---|---|
| NAME | Girish Prajapati |
| GIVEN NAMES | Girish |
| FAMILY NAME | Prajapati |
| SIGNATURE | PRAJAPATI G |
| AFFILIATIONS | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Weight gain and health-related quality of life in people living with HIV on antiretroviral therapy in the United States
Adverse weight gain has been reported to be associated with certain antiretroviral drugs. This study evaluated the association between weight gain and health-related quality of life (HRQoL) among people living with HIV (PLWH) using real-world data. Data were derived from the Adelphi HIV Disease Specific Programme (DSP)TM, a real-world, cross-sectional survey of physicians and virologically suppressed PLWH under their treatment, conducted in the U…
Adherence to antiretroviral therapy and its association with quality of life among people with HIV in the United States
Adherence to antiretroviral therapy (ART) is critical for people with HIV (PWH) to achieve and maintain virologic suppression and minimize drug resistance. This study aimed to use real-world data to characterize ART adherence and its effect on quality of life (QoL) in PWH. Data were drawn from the Adelphi HIV Disease Specific ProgrammeTM, a cross-sectional survey of physicians and PWH in the United States, conducted June-October 2021. Demographic…
Body mass index and quality of life in people living with HIV
With advances in the treatment of HIV, people living with HIV (PLWH) are now expected to have a near-normal life expectancy, but challenges remain in the form of substantially poorer health-related quality of life (HRQoL) than the general population. Being overweight or obese may pose an additional burden in PLWH, but few studies have evaluated the relationship between body mass index (BMI) and HRQoL in PLWH. This study aimed to evaluate and desc…
Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program
Approximately one-quarter of people with HIV (PWH) in the U.S. receive coverage through the Medicare program; however, no prior real-world study has examined antiretroviral therapy (ART) gaps and adherence and associated factors in this population. This retrospective cohort analysis used 2013-2018 national Medicare fee-for-service claims data to identify all PWH initiated on a new ART regimen including protease inhibitors [PI], non-nucleoside rev…
The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy
No prominent works on this page.
The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy
Body mass index and quality of life in people living with HIV
With advances in the treatment of HIV, people living with HIV (PLWH) are now expected to have a near-normal life expectancy, but challenges remain in the form of substantially poorer health-related quality of life (HRQoL) than the general population. Being overweight or obese may pose an additional burden in PLWH, but few studies have evaluated the relationship between body mass index (BMI) and HRQoL in PLWH. This study aimed to evaluate and desc…
Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program
Approximately one-quarter of people with HIV (PWH) in the U.S. receive coverage through the Medicare program; however, no prior real-world study has examined antiretroviral therapy (ART) gaps and adherence and associated factors in this population. This retrospective cohort analysis used 2013-2018 national Medicare fee-for-service claims data to identify all PWH initiated on a new ART regimen including protease inhibitors [PI], non-nucleoside rev…
Adherence to antiretroviral therapy and its association with quality of life among people with HIV in the United States
Adherence to antiretroviral therapy (ART) is critical for people with HIV (PWH) to achieve and maintain virologic suppression and minimize drug resistance. This study aimed to use real-world data to characterize ART adherence and its effect on quality of life (QoL) in PWH. Data were drawn from the Adelphi HIV Disease Specific ProgrammeTM, a cross-sectional survey of physicians and PWH in the United States, conducted June-October 2021. Demographic…
Weight gain and health-related quality of life in people living with HIV on antiretroviral therapy in the United States
Adverse weight gain has been reported to be associated with certain antiretroviral drugs. This study evaluated the association between weight gain and health-related quality of life (HRQoL) among people living with HIV (PLWH) using real-world data. Data were derived from the Adelphi HIV Disease Specific Programme (DSP)TM, a real-world, cross-sectional survey of physicians and virologically suppressed PLWH under their treatment, conducted in the U…
Gerontology (4 works) · HIV-related health complications and treatments (4 works) · HIV/AIDS Research and Interventions (4 works) · Medicine (4 works) · Antiretroviral therapy (3 works) · Family medicine (3 works) · Psychology (3 works) · Viral load (3 works) · Environmental health (2 works) · HIV, Drug Use, Sexual Risk (2 works)